Colorado State University veterinarians are for the first time investigating the use of stem-cell therapy to treat chronic liver disease in dogs, a novel approach they hope could lead to successful treatments for dogs and people. In a new study, veterinarians are looking at treatment of chronic...
CDC reinforces need for appropriate follow-up testing for current infection Only half of Americans identified as ever having had hepatitis C received follow-up testing showing that they were still infected, according to a Centers for Disease Control and Prevention analysis of data from a...
Sofosbuvir, a new drug, is offering impressive cure rates for Hepatitis C patients with two subtypes of the disease - genotypes 2 and 3, according to researchers led by Weill Cornell Medical College. Approximately 1 in every 4 hepatitis C patients in the USA has one of these two subtypes...
Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus (HCV), co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade. In a second study of HCV infection, the Johns Hopkins research team participated in the...
A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response to pegylated interferon-α plus ribavirin (PEG-IFN/RBV). Information...
Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds with and repurposes a basic component of cellular metabolism known as a microRNA to help...
Enzyme levels in the blood routinely monitored by physicians as liver function indicators are also the best predictor of liver cancer risk for the general population, a team of scientists in Taiwan and The University of Texas MD Anderson Cancer Center reports today in the Journal of the National...
Epidemiologists have determined that levels of hepatitis C virus (HCV) found among injection drug users (IDUs) were higher in individuals who are male or African American even after differences in other factors were considered. The study, which was funded by the National Cancer Institute and...
Scientists Have Discovered A "Switch" In The Hepatitis C Virus Which Could Be Used As
Hepatitis C affects more than 170 million people worldwide, but current combination treatment is only effective against a limited range of this naturally highly variable virus. However, according to new...
There's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression. In a review article, researchers tackle the complexities of diagnosing and managing depression before and after initiating treatment...
More people die per year from hepatitis C than HIV each year in the USA, and the number of people dying from hepatitis C or B occurs disproportionately in middle-aged individuals, researchers from the CDC (Centers for Disease Control and Prevention) reported in Annals of Internal Medicine. The...
About a month and a half ago I got my lip pierced professionaly and the other day the skin around my eyes is really dry l, like skin flaking dry. Is this a result of hepatitis c or is this unrelated?
The risk of hepatitis transmission through non-single use instruments - such as nail files, nail brushes, finger bowls, foot basins, buffers, razors, clippers, and scissors - during nail salon and barbershop visits cannot be excluded, according to the results of a new report unveiled at the...
Treatment with a telaprevir-based combination regimen for hepatitis C - heretofore a chronic, destructive and difficult to manage disease - effectively can be shortened to six months in about two-thirds of patients, finds a new study publishedin the New England Journal of Medicine. Telaprevir, a...
Widely available technology, expert training and real-time feedback helped ensure that patients treated for Hepatitis C in local communities did as well as patients treated at a university-based medical center, results of a new study funded by HHS' Agency for Healthcare Research and Quality...
Victrelis (boceprevir) has been approved by the FDA for adults with hepatitis C who have either never been treated with medications before or have not responded well to drug therapy. The FDA (Food and Drug Administration) approval is for Victrelis use alongside peginterferon alfa and ribavirin...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV)...
Scientists from the Florida campus of The Scripps Research Institute have identified a molecular interaction between a structural hepatitis C virus protein (HCV) and a protein critical to viral replication. This new finding strongly suggests a novel method of inhibiting the production of the...
A healthcare worker at a Worcestershire hospital contracted the Hepatitis C virus after injuring herself on a needle used to take blood from an infected patient. During the Health and Safety Executive (HSE) prosecution of Worcestershire Acute Hospitals NHS Trust over the February 2007 incident...